These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 37453993)
21. Neuroprotective actions of flavones and flavonols: mechanisms and relationship to flavonoid structural features. Dajas F; Andrés AC; Florencia A; Carolina E; Felicia RM Cent Nerv Syst Agents Med Chem; 2013 Mar; 13(1):30-5. PubMed ID: 23092407 [TBL] [Abstract][Full Text] [Related]
22. Ganoderic Acid A: A Potential Natural Neuroprotective Agent for Neurological Disorders: A Review. Ma F; Wang J; Jiang W; Luo J; Yang R; Zhang L; Han C Int J Med Mushrooms; 2024; 26(2):11-23. PubMed ID: 38421693 [TBL] [Abstract][Full Text] [Related]
23. Targeting endoplasmic reticulum stress using natural products in neurological disorders. Jangra A; Verma M; Kumar D; Chandrika ; Rachamalla M; Dey A; Dua K; Jha SK; Ojha S; Alexiou A; Kumar D; Jha NK Neurosci Biobehav Rev; 2022 Oct; 141():104818. PubMed ID: 35940309 [TBL] [Abstract][Full Text] [Related]
24. Prospects of molecular hydrogen in perioperative neuroprotection from basic research to clinical application. Wang Z; Wang G; Xie K Curr Opin Anaesthesiol; 2020 Oct; 33(5):655-660. PubMed ID: 32826628 [TBL] [Abstract][Full Text] [Related]
25. Fisetin Exerts Antioxidant and Neuroprotective Effects in Multiple Mutant hSOD1 Models of Amyotrophic Lateral Sclerosis by Activating ERK. Wang TH; Wang SY; Wang XD; Jiang HQ; Yang YQ; Wang Y; Cheng JL; Zhang CT; Liang WW; Feng HL Neuroscience; 2018 May; 379():152-166. PubMed ID: 29559385 [TBL] [Abstract][Full Text] [Related]
26. Carvacrol as a Potential Neuroprotective Agent for Neurological Diseases: A Systematic Review Article. Zamanian MY; Kujawska M; Nikbakhtzadeh M; Hassanshahi A; Ramezanpour S; Kamiab Z; Bazmandegan G CNS Neurol Disord Drug Targets; 2021; 20(10):942-953. PubMed ID: 33970850 [TBL] [Abstract][Full Text] [Related]
27. Fisetin and Its Role in Chronic Diseases. Pal HC; Pearlman RL; Afaq F Adv Exp Med Biol; 2016; 928():213-244. PubMed ID: 27671819 [TBL] [Abstract][Full Text] [Related]
28. Monoamine oxidase inhibitors and neuroprotection: a review. Al-Nuaimi SK; Mackenzie EM; Baker GB Am J Ther; 2012 Nov; 19(6):436-48. PubMed ID: 22960850 [TBL] [Abstract][Full Text] [Related]
29. Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders. Guzman DC; Olguin HJ; Garcia EH; Soto MP; Garcia MS; Mejia GB CNS Neurol Disord Drug Targets; 2017; 16(7):763-771. PubMed ID: 28714392 [TBL] [Abstract][Full Text] [Related]
30. The neuroprotective effect of fisetin in the MPTP model of Parkinson's disease. Patel MY; Panchal HV; Ghribi O; Benzeroual KE J Parkinsons Dis; 2012; 2(4):287-302. PubMed ID: 23938259 [TBL] [Abstract][Full Text] [Related]
31. Fisetin alleviates oxidative stress after traumatic brain injury via the Nrf2-ARE pathway. Zhang L; Wang H; Zhou Y; Zhu Y; Fei M Neurochem Int; 2018 Sep; 118():304-313. PubMed ID: 29792955 [TBL] [Abstract][Full Text] [Related]
32. Role of Fisetin in Selected Malignant Neoplasms in Women. Markowska A; Antoszczak M; Kacprzak K; Markowska J; Huczyński A Nutrients; 2023 Nov; 15(21):. PubMed ID: 37960338 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances. Cai B; Zhang Y; Wang Z; Xu D; Jia Y; Guan Y; Liao A; Liu G; Chun C; Li J Oxid Med Cell Longev; 2020; 2020():3153082. PubMed ID: 32215172 [TBL] [Abstract][Full Text] [Related]
35. Neuroprotective effect of geraniol on neurological disorders: a review article. Bagheri S; Salehi I; Ramezani-Aliakbari F; Kourosh-Arami M; Komaki A Mol Biol Rep; 2022 Nov; 49(11):10865-10874. PubMed ID: 35900613 [TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of Polygala saponins in neurological diseases. Zhang L; Yong YY; Deng L; Wang J; Law BY; Hu ML; Wu JM; Yu L; Wong VK; Yu CL; Qin DL; Zhou XG; Wu AG Phytomedicine; 2023 Jan; 108():154483. PubMed ID: 36260972 [TBL] [Abstract][Full Text] [Related]
37. Enhanced oral bioavailability and neuroprotective effect of fisetin through its SNEDDS against rotenone-induced Parkinson's disease rat model. Kumar R; Kumar R; Khurana N; Singh SK; Khurana S; Verma S; Sharma N; Kapoor B; Vyas M; Khursheed R; Awasthi A; Kaur J; Corrie L Food Chem Toxicol; 2020 Oct; 144():111590. PubMed ID: 32710995 [TBL] [Abstract][Full Text] [Related]
38. Astragalus species: Phytochemistry, biological actions and molecular mechanisms underlying their potential neuroprotective effects on neurological diseases. Abd Elrahim Abd Elkader HT; Essawy AE; Al-Shami AS Phytochemistry; 2022 Oct; 202():113293. PubMed ID: 35780924 [TBL] [Abstract][Full Text] [Related]
39. Literature Evidence and ARRIVE Assessment on Neuroprotective Effects of Flavonols in Neurodegenerative Diseases' Models. Bombardi Duarte AC; Santana MG; di Camilo Orfali G; de Oliveira CTP; Priolli DG CNS Neurol Disord Drug Targets; 2018 Apr; 17(1):34-42. PubMed ID: 29268692 [TBL] [Abstract][Full Text] [Related]
40. Fisetin ameliorates cognitive impairment by activating mitophagy and suppressing neuroinflammation in rats with sepsis-associated encephalopathy. Ding H; Li Y; Chen S; Wen Y; Zhang S; Luo E; Li X; Zhong W; Zeng H CNS Neurosci Ther; 2022 Feb; 28(2):247-258. PubMed ID: 34837343 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]